Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138191 | 0.89 | EGFR (0.50) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL17138133 | 0.89 | LMNA (0.49) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL5711151 | 0.86 | ALDH1A1 (0.57) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL3451753 | 0.85 | LMNA (0.56) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL421378 | 0.82 | BCL9 (0.53) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL18333384 | 0.82 | KMT2A (0.57) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL26564896 | 0.80 | LMNA (0.61) | LMNAKMT2AALDH1A1MEN1ACHE | |
| SCHEMBL17138157 | 0.79 | KMT2A (0.54) | LMNAKMT2AMAPTALDH1A1MEN1 | |
| SCHEMBL12742253 | 0.79 | LMNA (0.58) | LMNAKMT2AMAPTALDH1A1HTT | |
| SCHEMBL14579683 | 0.79 | CYP1A2 (0.62) | LMNAKMT2AMAPTALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | LMNA 1443/4885KMT2A 580/4885MAPT 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.